Sorry, you need to enable JavaScript to visit this website.

A-26/27-17

Supreme Court Appeal

Case Details:

Was plaintiffs’ evidence regarding a failure to warn sufficient to overcome the presumption of adequacy afforded by the Products Liability Act for an FDA-approved warning; and what is the appropriate resolution of the choice-of-law issues?

Case Dates:

  • Certification granted: Dec. 8, 2017
  • Posted: Dec. 8, 2017
  • Argued: April 23, 2018
  • Decided: Oct. 3, 2018